Gm1527 Inhibitors

The chemical class known as GM1527 Inhibitors refers to a group of compounds that can indirectly disrupt the activity of the GM1527 protein, a predicted GTPase activator. These inhibitors exert their effects not by binding directly to the GM1527 protein, but by modulating the signaling pathways and cellular processes that involve GTPases. They encompass a variety of mechanisms, such as preventing GTPase activation, impairing proper localization and function through interference with prenylation, or locking GTPases in an active state with non-hydrolyzable GTP analogs.

Members of this chemical class such as NSC 23766, CID 1067700, and ML141, inhibit the function of specific GTPases or their activators, which in turn can lead to a downstream inhibition of the proteins that regulate these GTPases, potentially including GM1527. Other compounds like SecinH3 or Brefeldin A target GDP-GTP exchange factors or disrupt functions of ARFs respectively, affecting the broader regulatory network within which GTPase activator proteins operate. Farnesyltransferase inhibitors, such as Lonafarnib, 1,8-Naphthalimide, L-778123, and FTI-277, prevent the post-translational modification of GTPases, which is critical for their activity and interaction with proteins like GM1527. This diverse class of chemicals shares the common feature of being able to modulate GTPase-related pathways, thus indirectly affecting the function of GM1527 or similar GTPase activator proteins.